Gen-Probe Inc. (GPRO: Quote) Tuesday said the US Food and Drug Administration has cleared its PANTHER system, a fully automated and integrated molecular testing platform designed with the flexibility to handle a wide range of testing needs.
The PANTHER system can initially be used to test for the common sexually transmitted infections Chlamydia trachomatis and Neisseria gonorrhoeae with the APTIMA Combo 2 assay.
According to the company, using this system, a single operator can process 275 samples in eight hours.
Gen-Probe will begin shipments of PANTHER systems to US customers during the second quarter.
Click here to receive FREE breaking news email alerts for Gen-Probe Inc. and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org